0001615774-17-001101.txt : 20170316 0001615774-17-001101.hdr.sgml : 20170316 20170316173640 ACCESSION NUMBER: 0001615774-17-001101 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170314 FILED AS OF DATE: 20170316 DATE AS OF CHANGE: 20170316 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SECOND SIGHT MEDICAL PRODUCTS INC CENTRAL INDEX KEY: 0001266806 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 000000000 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12744 SAN FERNANDO ROAD, BLDG. 3 CITY: SYLMAR STATE: CA ZIP: 91342 BUSINESS PHONE: 818-833-5000 MAIL ADDRESS: STREET 1: 12744 SAN FERNANDO ROAD, BLDG. 3 CITY: SYLMAR STATE: CA ZIP: 91342 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McGuire Jonathan Will CENTRAL INDEX KEY: 0001345539 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36747 FILM NUMBER: 17695662 MAIL ADDRESS: STREET 1: 96 TALAMINE COURT CITY: COLORADO SPRINGS STATE: CO ZIP: 80907 4 1 s105584_form4.xml OWNERSHIP DOCUMENT X0306 4 2017-03-14 0 0001266806 SECOND SIGHT MEDICAL PRODUCTS INC EYES 0001345539 McGuire Jonathan Will 12744 SAN FERNANDO ROAD SUITE 400 SYLMAR CA 91342 0 1 0 0 Chief Executive Officer Common Stock 2017-03-14 2017-03-14 4 A 0 6794 1.47 A 59798 D Warrant to Purchase Common Stock 1.47 2017-03-14 4 A 0 6794 A 2017-03-14 2022-03-14 Common Stock 6794 6794 D Non-Qualified Stock Option (right to buy) 1.97 2018-01-03 2027-01-03 Common Stock 571330 571330 D Non-Qualified Stock Option (right to buy) 4.1 2017-01-21 2026-01-21 Common Stock 21290 21290 D Non-Qualified Stock Option (right to buy) 12.43 2016-08-17 2025-08-17 Common Stock 420000 420000 D Restricted Stock Unit (RSU) 2016-08-17 2019-08-17 Common Stock 190000 118750 D Common stock and warrants reported on this Form 4 pursuant to an exercise of subscription rights previously distributed by the Company to all holders of the Company's common stock. Each stockholder received a right to invest $0.47 for every share held of record on February 10, 2017, the record date, to purchase units consisting of one share of common stock and one warrant to purchase one share of common stock. The final allocation numbers of units were distributed on March 14, 2017. Options and RSUs vest over a 4 year term, with 25% vesting on the date exercisable as set forth in this Form 4 and thereafter vesting in 12 equal quarterly installments of 6.25%. Each restricted stock unit represents a contingent right to receive one share of common stock of the Company. /s/ Jonathan Will McGuire 2017-03-16